Finn Sawyer Access to Cancer Testing Act has not moved since its introduction on Feb 26, 2025, with cosponsors from both parties
IntroducedFeb 26, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
Written by the Congressional Research Service [2]. 82 words.
Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Context
- Committees
- House Energy and Commerce Committee
House Ways and Means Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 6 of 154 bills enacted since 2013
- Text versions
- 1: introduced in house · 1,035 words
- Subjects
- CancerHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicaidMedical tests and diagnostic methods +3 more
- Latest action
- Feb 26, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 1
Each bill appears once, under its strongest link. 1 in all.
Related, per CRS or House · 1
- 119th S. 755 Finn Sawyer Access to Cancer Testing Act R · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]